개인구독
소속 기관이 없으신 경우, 개인 정기구독을 하시면 저렴하게
논문을 무제한 열람 이용할 수 있어요.
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2023.4
- 수록면
- 320 - 331 (12page)
이용수
초록· 키워드
오류제보하기
The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) has increased among the general population and chronic hepatitis B (CHB) patients worldwide. Although fatty liver disease is a well-known risk factor for adverse liver outcomes like cirrhosis and hepatocellular carcinoma, its interactions with the hepatitis B virus (HBV) and clinical impacts seem complex. The presence of hepatic steatosis may suppress HBV viral activity, potentially leading to attenuated liver injury. In contrast, the associated co-morbidities like diabetes mellitus or obesity may increase the risk of developing adverse liver outcomes. These findings implicate that components of MAFLD may have diverse effects on the clinical manifestations of CHB. To this end, a clinical strategy is proposed for managing patients with concurrent CHB and MAFLD. This review article discusses the updated evidence regarding disease prevalence, interactions between steatosis and HBV, clinical impacts, and management strategies, aiming at optimizing holistic health care in the CHB population.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Clinical and Molecular Hepatology
2022 .04
-
From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Clinical and Molecular Hepatology
2021 .01
-
Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease
Gut and Liver
2021 .01
-
Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
Diabetes and Metabolism Journal
2023 .03
-
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
Clinical and Molecular Hepatology
2023 .02
-
Effect of Korean Red Ginseng in chronic liver disease
Journal of Ginseng Research
2017 .10
-
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
Clinical and Molecular Hepatology
2023 .04
-
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases
Clinical and Molecular Hepatology
2024 .01
-
Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study
Diabetes and Metabolism Journal
2023 .03
-
The Epidemiology of Hepatitis B Virus Infection in Korea: 15-Year Analysis
Journal of Korean Medical Science
2024 .01
-
Erectile dysfunction in patients with liver disease related to chronic hepatitis B
Clinical and Molecular Hepatology
2015 .01
-
Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions
Gut and Liver
2022 .07
-
Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017
Diabetes and Metabolism Journal
2023 .05
-
Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”
Clinical and Molecular Hepatology
2024 .01
-
How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
Clinical and Molecular Hepatology
2023 .04
-
Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
Clinical and Molecular Hepatology
2020 .01
-
MAFLD: How is it different from NAFLD?
Clinical and Molecular Hepatology
2023 .02
-
Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
Diabetes and Metabolism Journal
2022 .07
-
Change in fatty liver status and 5-year risk of incident metabolic syndrome: a retrospective cohort study
Clinical Hypertension
2015 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0